Cancer | Australian Biotech News

Home Tags Cancer

Ngaiire Media

Special fibroblasts help pancreatic cancer cells evade immune detection

Ngaiire - June 13, 2019

Ngaiire Media

A gut feeling: Microbiome changes may mean early detection of colorectal...

Ngaiire - June 12, 2019

Ngaiire Media

SU2C hails FDA approval of alpelisib and fulvestrant new breast cancer...

Ngaiire - June 11, 2019

Ngaiire Media

Highlights from European Biotech at ASCO 2019

Ngaiire - June 5, 2019

Ngaiire Media

Enzalutamide improves survival for men with metastatic hormone-sensitive prostate cancer

Ngaiire - June 2, 2019

Ngaiire Media

Ribociclib plus hormone therapy extends survival for patients with premenopausal advanced...

Ngaiire - June 1, 2019

Ngaiire Media

Early genome catastrophes can cause non-smoking lung cancer

Ngaiire - May 31, 2019

Ngaiire Media

Taking a Drug to Market “Is a Marathon, Not a Sprint”

Ngaiire - May 16, 2019

Ngaiire Media

‘Guided Missile’ Cancer Immunotherapy Boosted by €62M Funding

Ngaiire - May 13, 2019

Ngaiire Media

New Mexico cancer patients have lower survival rate, study finds

Ngaiire - May 13, 2019

12 Page 1 of 2

Stay connected

Recent posts

MDR: an integrative DNA N6-methyladenine and N4-methylcytosine modification database for Rosaceae

Ngaiire - June 15, 2019

High tunnels for specialty crops: The hope and the hinderance

Ngaiire - June 14, 2019

First Gene Therapy for Beta Thalassemia Will Cost Over €1.5M

Ngaiire - June 14, 2019

Random article

MDR: an integrative DNA N6-methyladenine and N4-methylcytosine modification database for Rosaceae

High tunnels for specialty crops: The hope and the hinderance

First Gene Therapy for Beta Thalassemia Will Cost Over €1.5M

How do engineers form subjective opinions from objective data?